Literature DB >> 19804566

Pivotal role of translokin/CEP57 in the unconventional secretion versus nuclear translocation of FGF2.

Sylvain Meunier1, Marina García-Jove Navarro, Carine Bossard, Henrik Laurell, Christian Touriol, Eric Lacazette, Hervé Prats.   

Abstract

Intracellular trafficking of fibroblast growth factor 2 (FGF2) exhibits two unusual features: (i) it is secreted despite the lack of signal peptide and (ii) it can translocate to the nucleus after interaction with high- and low-affinity receptors on the cell surface, although it does not possess any classical nuclear localization signal. This nuclear translocation constitutes an important part of the response to the growth factor. Previously, we identified Translokin/CEP57, an FGF2 binding partner, as an intracellular mediator of FGF2 trafficking, which is essential for the nuclear translocation of the growth factor. Here, we report the identification of four Translokin partners: sorting nexin 6, Ran-binding protein M and the kinesins KIF3A and KIF3B. These proteins, through their interaction with Translokin, are involved in two exclusive complexes allowing the bidirectional trafficking of FGF2. Thus, Translokin plays a pivotal role in this original mechanism. In addition, we show that FGF2 secretion is regulated by a negative loop, retro-controlled by FGF receptor and involving FGF2 itself.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804566     DOI: 10.1111/j.1600-0854.2009.00985.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  10 in total

1.  Cep57, a NEDD1-binding pericentriolar material component, is essential for spindle pole integrity.

Authors:  Qixi Wu; Runsheng He; Haining Zhou; Albert C H Yu; Bo Zhang; Junlin Teng; Jianguo Chen
Journal:  Cell Res       Date:  2012-04-17       Impact factor: 25.617

2.  Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer.

Authors:  Julia G Poirier; Paul Brennan; James D McKay; Margaret R Spitz; Heike Bickeböller; Angela Risch; Geoffrey Liu; Loic Le Marchand; Shelley Tworoger; John McLaughlin; Albert Rosenberger; Joachim Heinrich; Irene Brüske; Thomas Muley; Brian E Henderson; Lynne R Wilkens; Xuchen Zong; Yafang Li; Ke Hao; Wim Timens; Yohan Bossé; Don D Sin; Ma'en Obeidat; Christopher I Amos; Rayjean J Hung
Journal:  Genet Epidemiol       Date:  2015-01-19       Impact factor: 2.135

3.  Cep57 protein is required for cytokinesis by facilitating central spindle microtubule organization.

Authors:  Runsheng He; Qixi Wu; Haining Zhou; Ning Huang; Jianguo Chen; Junlin Teng
Journal:  J Biol Chem       Date:  2013-04-08       Impact factor: 5.157

4.  Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease.

Authors:  Valérie Vingtdeux; Nicolas Sergeant; Luc Buée
Journal:  Front Physiol       Date:  2012-07-05       Impact factor: 4.566

5.  Prognostic Significance and Functional Role of CEP57 in Prostate Cancer.

Authors:  Josef Mang; Nina Korzeniewski; Dimo Dietrich; Verena Sailer; Yanis Tolstov; Sam Searcy; Jost von Hardenberg; Sven Perner; Glen Kristiansen; Alexander Marx; Wilfried Roth; Esther Herpel; Carsten Grüllich; Valentin Popeneciu; Sascha Pahernik; Boris Hadaschik; Markus Hohenfellner; Stefan Duensing
Journal:  Transl Oncol       Date:  2015-12       Impact factor: 4.243

6.  A novel CEP57 variant associated with mosaic variegated aneuploidy syndrome in a Chinese female presenting with short stature, microcephaly, brachydactyly, and small teeth.

Authors:  Biyun Feng; Guoying Chang; Qianwen Zhang; Xin Li; Yijun Tang; Shili Gu; Yirou Wang; Jian Wang; Xiumin Wang
Journal:  Mol Genet Genomic Med       Date:  2022-04-17       Impact factor: 2.473

7.  A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort.

Authors:  Shashwath A Meda; Balaji Narayanan; Jingyu Liu; Nora I Perrone-Bizzozero; Michael C Stevens; Vince D Calhoun; David C Glahn; Li Shen; Shannon L Risacher; Andrew J Saykin; Godfrey D Pearlson
Journal:  Neuroimage       Date:  2012-01-08       Impact factor: 6.556

8.  Mutations in CEP57 cause mosaic variegated aneuploidy syndrome.

Authors:  Katie Snape; Sandra Hanks; Elise Ruark; Patricio Barros-Núñez; Anna Elliott; Anne Murray; Andrew H Lane; Nora Shannon; Patrick Callier; David Chitayat; Jill Clayton-Smith; David R Fitzpatrick; David Gisselsson; Sebastien Jacquemont; Keiko Asakura-Hay; Mark A Micale; John Tolmie; Peter D Turnpenny; Michael Wright; Jenny Douglas; Nazneen Rahman
Journal:  Nat Genet       Date:  2011-05-08       Impact factor: 38.330

9.  Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1).

Authors:  Torunn Sletten; Michal Kostas; Joanna Bober; Vigdis Sorensen; Mandana Yadollahi; Sjur Olsnes; Justyna Tomala; Jacek Otlewski; Malgorzata Zakrzewska; Antoni Wiedlocha
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  Mosaic-variegated aneuploidy syndrome mutation or haploinsufficiency in Cep57 impairs tumor suppression.

Authors:  Khaled Aziz; Cynthia J Sieben; Karthik B Jeganathan; Masakazu Hamada; Brian A Davies; Raul O Fierro Velasco; Nazneen Rahman; David J Katzmann; Jan M van Deursen
Journal:  J Clin Invest       Date:  2018-07-23       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.